Securities Code: 300862 Securities Abbreviation: Blue Shield Optoelectronics Announcement No.: 2026-046
Anhui Blue Shield Optoelectronics Co., Ltd.
Announcement on Abnormal Stock Trading Fluctuations
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Key Information Prompt:
-
Anhui Blue Shield Optoelectronics Co., Ltd. (hereinafter referred to as the "Company" or "this Company") experienced abnormal stock trading fluctuations, with the cumulative closing price increase exceeding 30% over two consecutive trading days (August 10, 2026, and August 11, 2026), in accordance with the "Trading Rules of Shenzhen Stock Exchange" and other relevant regulations.
-
After self-inspection by the Company and inquiry to the controlling shareholder, actual controller, and their concerted parties, it is confirmed that as of the disclosure date of this announcement, there are no major undisclosed matters.
-
The Company's operating revenue in 2025 was 39,897.11 million yuan, a year-on-year decrease of 34.53%; the net profit attributable to shareholders of the listed company was -8,876.65 million yuan, a year-on-year decrease of 1,468.72%. The Company's operating revenue in the first quarter of 2026 was 8,811.63 million yuan, a year-on-year decrease of 13.20%; the net profit attributable to shareholders of the listed company was -866.43 million yuan, a year-on-year decrease of 271.99%. Overall, the Company's overall operating performance still faces significant challenges. Investors are advised to invest rationally and be aware of risks.
-
The Company plans to acquire the controlling stake of Suzhou Lancuang Technology Co., Ltd. and raise supporting funds by issuing shares and paying cash to seven counterparties including Li Xia (hereinafter referred to as "this transaction"). This transaction still needs to undergo multiple approval procedures before implementation, including but not limited to the Company's board of directors re-examining the transaction plan, the Company's shareholders' meeting approving the transaction plan, the counterparties completing all necessary internal decision-making procedures, and the Shenzhen Stock Exchange's review and approval and the China Securities Regulatory Commission's registration. This transaction is subject to approval risks, and may be suspended, terminated, or cancelled, and its subsequent progress faces significant uncertainty. Investors are advised to invest rationally and be aware of risks.
I. Introduction to Abnormal Stock Trading Fluctuations
The Company's stock price has experienced abnormal trading fluctuations, with the cumulative closing price increase exceeding 30% over two consecutive trading days (August 10, 2026, and August 11, 2026), in accordance with the "Trading Rules of Shenzhen Stock Exchange" and other relevant regulations.